ReviewOncoTargets and therapy2017

Distinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancer.

Robert L Hollis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.